Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Both steroids effectively promote hair growth for at least 9 months.

Hormonal therapies effectively treat acne and improve quality of life.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.